Kellar, KJ, Cascio, CS, Butler, JA, Kurtzke, RN. Differential-effects of electroconvulsive shock and anti-depressant drugs on serotonin-2 receptors in rat-brain. Eur J Pharmacol
1981; 69: 515–8.
Peroutka, SJ, Snyder, SH. Long-term anti-depressant treatment decreases spiroperidol-labeled serotonin receptor-binding. Science
1980; 210: 88–90.
Eison, AS, Yocca, FD, Gianutsos, G. Effect of chronic administration of antidepressant drugs on 5-HT2-mediated behavior in the rat following nor-adrenergic or serotonergic denervation. J Neural Transm Gen Sect
1991; 84: 19–32.
Blackshear, MA, Sandersbush, E. Serotonin receptor sensitivity after acute and chronic treatment with Mianserin. J Pharmacol Exp Ther
1982; 221: 303–8.
Yatham, LN, Liddle, PF, Dennie, J, Shiah, IS, Adam, MJ, Lane, CJ, et al. Decrease in brain serotonin-2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperone. Arch Gen Psychiatry
1999; 56: 705–11.
Meyer, JH, Kapur, S, Eisfeld, B, Brown, GM, Houle, S, DaSilva, J, et al. The effect of paroxetine on 5-HT2A receptors in depression: an [F-18]setoperone PET imaging study. Am J Psychiatry
2001; 158: 78–85.
Mischoulon, D, Dougherty, DD, Bottonari, KA, Gresham, RL, Sonawalla, SB, Fischman, AJ, et al. An open pilot study of nefazodone in depression with anger attacks: relationship between clinical response and receptor binding. Psychiatry Res
2002; 116: 151–61.
Meyer, JH. Applying neuroimaging ligands to study major depressive disorder. Semin Nucl Med
2008; 38: 287–304.
Blin, J, Sette, G, Fiorelli, M, Bletry, O, Elghozi, JL, Crouzel, C, et al. A method for the in-vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral-cortex using positron emission tomography and F-18 labeled setoperone. J Neurochem
1990; 54: 1744–54.
Crouzel, C, Guillaume, M, Barre, L, Lemaire, C, Pike, VW. Ligands and tracers for PET studies of the 5-HT system – current status. Nucl Med Biol
1992; 19: 857–70.
First, MB, Spitzer, RL, Gibbon, M, Williams, JBW. Structured Clinical Interview for DSM–IV–TR Axis I Disorders: Research Version, Patient Edition (SCID–I/P). Biometrics Research, 2002.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM–IV). APA, 1994.
Hamilton, M. Citation classic – a rating-scale for depression. Curr Contents Clin Pract
1981; 33: 18.
Williams, JBW, Link, MJ, Rosenthal, NE, Terman, M. Structured Interview Guide for the Hamilton Depression Rating Scale, Seasonal Affective Disorders version (SIGH-SAD). New York State Psychiatric Institute, 1988.
Yatham, LN, Liddle, PF, Shiah, IS, Scarrow, G, Lam, RW, Adam, MJ, et al. Brain serotonin2 receptors in major depression: a positron emission tomography study. Arch Gen Psychiatry
2000; 57: 850–8.
Shiah, IS, Yatham, LN, Srisurapanont, M, Lam, RW, Tam, EM, Zis, AP. Does the addition of pindolol accelerate the response to electroconvulsive therapy in patients with major depression? A double-blind, placebo-controlled pilot study. J Clin Psychopharmacol
2000; 20: 373–8.
Petit-Taboue, MC, Landeau, B, Barre, L, Onfroy, MC, Noel, MH, Baron, JC. Parametric PET imaging of 5HT(2A) receptor distribution with F-18-setoperone in the normal human neocortex. J Nucl Med
1999; 40: 25–32.
Desjardins, AE, Kiehl, KA, Liddle, PF. Removal of confounding effects of global signal in functional MRI analyses. Neuroimage
2001; 13: 751–58.
Worsley, KJ. Local maxima and the expected euler characteristic of excursion sets of chi(2), F and T fields. Adv Appl Probab
1994; 26: 13–42.
Friston, KJ, Frith, CD, Liddle, PF, Frackowiak, RSJ. Comparing functional (Pet) images – the assessment of significant change. J Cerebr Blood F Met
1991; 11: 690–9.
Genovese, CR, Lazar, NA, Nichols, T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage
2002; 15: 870–8.
Logan, J, Fowler, JS, Volkow, ND, Wang, GJ, Ding, YS, Alexoff, DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cerebr Blood F Metab
1996; 16: 834–40.
Klimek, V, Zak-Knapik, J, Mackowiak, M. Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain. J Psychiatry Neurosci
1994; 19: 63–7.
Kellar, KJ, Stockmeier, CA. Effects of electroconvulsive shock and serotonin axon lesions on beta-adrenergic and serotonin-2 receptors in rat-brain. Ann NY Acad Sci
1986; 462: 76–90.
Vetulani, J, Lebrecht, U, Pilc, A. Enhancement of responsiveness of the central serotonergic system and serotonin-2 receptor density in rat frontal-cortex by electroconvulsive treatment. Eur J Pharmacol
1981; 76: 81–5.
Strome, EM, Clark, CM, Zis, AP, Doudet, DJ. Electroconvulsive shock decreases binding to 5-HT2 receptors in nonhuman primates: an in vivo positron emission tomography study with [F-18]setoperone. Biol Psychiatry
2005; 57: 1004–10.
Mayberg, H, Goldapple, K, MacIntosh, AR. Is there a final common pathway mediating depression remission? The functional neuroimaging evidence. Biol Psychiatry
2002; 51: 7–8S.
Mayberg, H. Towards a neural systems model of depression: evidence of dysfunctional limbic-cortical circuits. Clin Neuropsychol
2003; 17: 85–6.
D'haenen, H, Bossuyt, A, Mertens, J, Bossuyt-Piron, C, Gijsemans, M, Kaufman, L. SPECT imaging of serotonin-2 receptors in depression. Psychiatry Res
1992; 45: 227–37.
Biver, F, Wikler, D, Lotstra, F, Damhaut, P, Goldman, S, Mendlewicz, J. Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex. Br J Psychiatry
1997; 171: 444–8.
Schotte, A, Maloteaux, JM, Laduron, PM. Characterization and regional distribution of serotonin S2-receptors in human brain. Brain Res
1983; 276: 231–5.
Mintun, MA, Sheline, YI, Moerlein, SM, Vlassenko, AG, Huang, YY, Snyder, AZ. Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [F-18]Altanserin positron emission tomography. Biol Psychiatry
2004; 55: 217–24.
Meyer, JH, McMain, S, Kennedy, SH, Korman, L, Brown, GM, DaSilva, JN, et al. Dysfunctional attitudes and 5-HT2 receptors during depression and selfharm. Am J Psychiatry
2003; 160: 90–9.
Bhagwagar, Z, Hinz, R, Taylor, M, Fancy, S, Cowen, P, Grasby, P. Increased 5-HT2A receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [C-11] MDL 100,907. Am J Psychiatry
2006; 163: 1580–7.
Tarazi, FI, Zhang, KH, Baldessarini, RJ. Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions. Psychopharmacol
2002; 161: 263–70.
Tohen, M, Vieta, E, Calabrese, J, Ketter, TA, Sachs, G, Bowden, C, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry
2003; 60: 1079–88.
Calabrese, JR, Keck, PE, Macfadden, W, Minkwitz, M, Ketter, TA, Weisler, RH, et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry
2005; 162: 1351–60.
Burnet, PWJ, Chen, CPLH, McGowan, S, Franklin, M, Harrison, PJ. The effects of clozapine and haloperidol on serotonin-1A, -2A and -2C receptor gene expression and serotonin metabolism in the rat forebrain. Neuroscience
1996; 73: 531–40.
Tohen, M, Goldberg, JF, Arrillaga, AMGP, Azorin, JM, Vieta, E, Hardy-Bayle, MC, et al. A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania. Arch Gen Psychiatry
2003; 60: 1218–26.
Yatham, LN, Liddle, PF, Shiah, IS, Lam, RW, Adam, MJ, Zis, AP, et al. Effects of rapid tryptophan depletion on brain 5-HT(2) receptors: a PET study. Br J Psychiatry
2001; 178: 448–53.
Mamo, D, Sedman, E, Tillner, J, Sellers, EM, Romach, MK, Kapur, S. EMD 281014, a specific and potent 5HT2 antagonist in humans: a dose-finding PET study. Psychopharmacol (Berl)
2004; 175: 382–8.
Elfving, B, Bjornholm, B, Knudsen, GM. Interference of anaesthetics with radioligand binding in neuroreceptor studies. Eur J Nucl Med Mol Imaging
2003; 30: 912–5.
Chow, TW, Mamo, DC, Uchida, H, Graff-Guerrero, A, Houle, S, Smith, GS, et al. Test-retest variability of high resolution positron emission tomography (PET) imaging of cortical serotonin (5HT2A) receptors in older, healthy adults. BMC Med Imaging
2009; 9: 12.